Articles by Walter Armstrong - Pharmaceutical Executive

ADVERTISEMENT

Articles by Walter Armstrong

Forecast 2009: Up in the Air

Jan 1, 2009

We know what you're thinking: new president, rotten economy, patent cliff. Do you feel Evel? Well, do you?

The New Deals

Dec 1, 2008

Everything you wanted to know about the year's most important deals—and what to watch for in the future

Global Warming

The Japanese Pharma League has spent almost $50 billion in a whirlwind year of foreign deals. But as the case of Astellas illustrates, becoming a global player in a game of catch-up will cost more than just money
Oct 1, 2008

Japan is playing a game of catch-up, dropping big cash on biotechs and risky acquisitions. But with patents expiring and sales falling, can they really pay their way to global success?

The Drug Vote '08

A head-to-head analysis of the two brands
Oct 1, 2008

A head-to-head comparison of the Drug Vote '08

The M&A Numbers

Sep 1, 2008

Young & Partners crunches pharma's filings for, the first half of '08. The results? Ask the Japanese

RNA Revolutionaries

Could gene silencing be the next great innovation in drug development? Led by Alnylam, Isis, and Regulus, a bold bunch of biotechs are betting on it
Jul 1, 2008

Could gene silencing be the next great innovation in drug development? Some biotechs are betting on it.

That Thing about RNA

No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics
Jul 1, 2008

No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics

45 Under 45:The Change Generation

Jun 1, 2008

In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead pharma into the next generation

The Incredible Shrinking Dollar

May 1, 2008

A plunging currency and other economic turmoil shouldn't phase pharma, right? Yes and no

ADVERTISEMENT

Click here